Cargando…
Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience
BACKGROUND: Vascularized composite allotransplantation is constrained by complications associated with standard immunosuppressive strategies. Vascularized thymus and bone marrow have been shown to promote prolonged graft survival in composite organ and soft-tissue vascularized composite allotranspla...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889452/ https://www.ncbi.nlm.nih.gov/pubmed/29632759 http://dx.doi.org/10.1097/GOX.0000000000001538 |
_version_ | 1783312697845088256 |
---|---|
author | Sendil, Selin Diaconu, Silviu C. O’Neill, Natalie A. Burdorf, Lars Tatarov, Ivan Parsell, Dawn M. Azimzadeh, Agnes M. Pierson, Richard N. Nam, Arthur J. |
author_facet | Sendil, Selin Diaconu, Silviu C. O’Neill, Natalie A. Burdorf, Lars Tatarov, Ivan Parsell, Dawn M. Azimzadeh, Agnes M. Pierson, Richard N. Nam, Arthur J. |
author_sort | Sendil, Selin |
collection | PubMed |
description | BACKGROUND: Vascularized composite allotransplantation is constrained by complications associated with standard immunosuppressive strategies. Vascularized thymus and bone marrow have been shown to promote prolonged graft survival in composite organ and soft-tissue vascularized composite allotransplantation models. We report development of a nonhuman primate vascularized thymosternal composite tissue transplant model as a platform to address donor-specific immune tolerance induction strategies. METHODS: Vascularized thymosternal allograft (skin, muscle, thymus, sternal bone) was transplanted between MHC-mismatched rhesus monkeys (feasibility studies) and baboons (long-term survival studies), with end-to-side anastomoses of the donor aorta and SVC to the recipient common femoral vessels. A male allograft was transplanted to a female’s lower abdominal wall, and clinically applicable immunosuppression was given. Skin biopsies and immunological assays were completed at regular intervals, and chimerism was quantified using polymerase chain reaction specific for baboon Y chromosome. RESULTS: Four allo- and 2 xenotransplants were performed, demonstrating consistent technical feasibility. In 1 baboon thymosternal allograft recipient treated with anti-CD40–based immunosuppression, loss of peripheral blood microchimerism after day 5 was observed and anticipated graft rejection at 13 days. In the second allograft, when cutaneous erythema and ecchymosis with allograft swelling was treated with anti-thymocyte globulin starting on day 6, microchimerism persisted until immunosuppression was reduced after the first month, and the allograft survived to 87 days, 1 month after cessation of immunosuppression treatment. CONCLUSIONS: We established both allo- and xeno- composite vascularized thymosternal transplant preclinical models, which will be useful to investigate the role of primarily vascularized donor bone marrow and thymus. |
format | Online Article Text |
id | pubmed-5889452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-58894522018-04-09 Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience Sendil, Selin Diaconu, Silviu C. O’Neill, Natalie A. Burdorf, Lars Tatarov, Ivan Parsell, Dawn M. Azimzadeh, Agnes M. Pierson, Richard N. Nam, Arthur J. Plast Reconstr Surg Glob Open Experimental BACKGROUND: Vascularized composite allotransplantation is constrained by complications associated with standard immunosuppressive strategies. Vascularized thymus and bone marrow have been shown to promote prolonged graft survival in composite organ and soft-tissue vascularized composite allotransplantation models. We report development of a nonhuman primate vascularized thymosternal composite tissue transplant model as a platform to address donor-specific immune tolerance induction strategies. METHODS: Vascularized thymosternal allograft (skin, muscle, thymus, sternal bone) was transplanted between MHC-mismatched rhesus monkeys (feasibility studies) and baboons (long-term survival studies), with end-to-side anastomoses of the donor aorta and SVC to the recipient common femoral vessels. A male allograft was transplanted to a female’s lower abdominal wall, and clinically applicable immunosuppression was given. Skin biopsies and immunological assays were completed at regular intervals, and chimerism was quantified using polymerase chain reaction specific for baboon Y chromosome. RESULTS: Four allo- and 2 xenotransplants were performed, demonstrating consistent technical feasibility. In 1 baboon thymosternal allograft recipient treated with anti-CD40–based immunosuppression, loss of peripheral blood microchimerism after day 5 was observed and anticipated graft rejection at 13 days. In the second allograft, when cutaneous erythema and ecchymosis with allograft swelling was treated with anti-thymocyte globulin starting on day 6, microchimerism persisted until immunosuppression was reduced after the first month, and the allograft survived to 87 days, 1 month after cessation of immunosuppression treatment. CONCLUSIONS: We established both allo- and xeno- composite vascularized thymosternal transplant preclinical models, which will be useful to investigate the role of primarily vascularized donor bone marrow and thymus. Wolters Kluwer Health 2017-12-22 /pmc/articles/PMC5889452/ /pubmed/29632759 http://dx.doi.org/10.1097/GOX.0000000000001538 Text en Copyright © 2017 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Experimental Sendil, Selin Diaconu, Silviu C. O’Neill, Natalie A. Burdorf, Lars Tatarov, Ivan Parsell, Dawn M. Azimzadeh, Agnes M. Pierson, Richard N. Nam, Arthur J. Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience |
title | Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience |
title_full | Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience |
title_fullStr | Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience |
title_full_unstemmed | Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience |
title_short | Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience |
title_sort | vascularized thymosternal composite tissue allo- and xenotransplantation in nonhuman primates: initial experience |
topic | Experimental |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889452/ https://www.ncbi.nlm.nih.gov/pubmed/29632759 http://dx.doi.org/10.1097/GOX.0000000000001538 |
work_keys_str_mv | AT sendilselin vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience AT diaconusilviuc vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience AT oneillnataliea vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience AT burdorflars vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience AT tatarovivan vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience AT parselldawnm vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience AT azimzadehagnesm vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience AT piersonrichardn vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience AT namarthurj vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience |